Microglia-derived exosomal circZNRF1 alleviates paraquat-induced neuronal cell damage via miR-17-5p

Xu Liu1, Qingqing Wu1, Jingwen Wu1

  • 1Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou 350122, China.

Insights

Paraquat exposure triggers Parkinson's-like symptoms. Microglia-derived exosomes carrying circZNRF1 protect neurons by inhibiting apoptosis via the miR-17-5p/Bcl2 pathway, offering a novel therapeutic target for Parkinson's disease.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Toxicology

Background:

  • Paraquat (PQ) exposure mimics Parkinson's disease (PD) symptoms by inducing dopaminergic neuron apoptosis and microglial activation.
  • The precise role of microglial activation in PQ-induced neurodegeneration is not fully understood.

Purpose of the Study:

  • To investigate the mechanism of microglial activation in PQ-induced neurodegeneration.
  • To explore the role of microglia-derived exosomes and circZNRF1 in protecting dopaminergic neurons.

Main Methods:

  • Isolation of microglia-derived exosomes exposed to PQ.
  • Co-incubation of exosomes with PQ-exposed neuronal cells.
  • RNA sequencing to identify exosomal cargo.
  • Bioinformatic analysis to predict molecular interactions.
  • Validation of molecular pathways involved in apoptosis.

Main Results:

  • Exosomes from PQ-activated microglia reversed PQ-induced neuronal apoptosis.
  • Activated microglia-derived exosomes were enriched with circZNRF1.
  • circZNRF1 was found to sponge miR-17-5p, leading to increased Bcl2 expression and an elevated Bcl2/Bax ratio.
  • This mechanism protected dopaminergic neurons from PQ-induced apoptosis.

Conclusions:

  • A novel intercellular communication pathway involving microglia-derived exosomes and circZNRF1 in neuroprotection against PQ toxicity was identified.
  • circZNRF1 protects dopaminergic neurons by modulating the miR-17-5p/Bcl2 axis, offering a potential therapeutic strategy for Parkinson's disease.

Related Concept Videos